StockData
SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31

DNA X, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$3.31+0.04 (+1.22%)

Close on Oct 19, 2026

Market cap
$4.47M
P/E (TTM)
–
Dividend yield
–

About DNA X

Telephone & Telegraph Apparatus, SIC 3661

DNA X, Inc. provides an online cryptocurrency trading and swapping platform to individual retail traders. The platform enables users to buy and sell cryptocurrencies using cash or cash equivalents, exchange pairs of digital currencies directly, and implement automated trading strategies that execute when relative price ratios diverge or converge. The business operates a non-custodial model in which clients retain direct ownership of their crypto assets both before and after trades, with commissions automatically deducted from executed transactions.

The company delivers its trading services to individual cryptocurrency traders worldwide via its website. Originally operating as Sonim Technologies, Inc. with a primary focus on designing and manufacturing mobile phones and mobile hotspots, the company entered digital asset services after acquiring its trading platform in December 2025 and divesting its hardware operations in January 2026. DNA X is incorporated in Delaware and maintains its principal executive offices in San Diego, California.

Summary of the business section of DNA X's latest annual report, written by StockData.

Company profile

Company

Legal name
DNA X, Inc.
Founded
1999
Headquarters
San Diego, CA
Address
4445 Eastgate Mall, Suite 200 92121
Phone
(650) 378-8100
Website
dnax.us
Employees
4, Dec 31, 2025
Industry
Telephone & Telegraph Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Baker Tilly US, LLP, San Jose, CA

Stock & identifiers

Ticker
SONM
Exchange
Nasdaq
IPO date
May 13, 2019
Shares outstanding
1M, Aug 18, 2026
Public float
$12.60M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-18 reverse, Oct 31, 2025; 1-for-18 reverse, Oct 27, 2025; 1-for-9.67 reverse, Aug 9, 2024; 1-for-10 reverse, Jul 18, 2024; 1-for-10 reverse, Nov 12, 2021; 1-for-10 reverse, Sep 16, 2021
SEC CIK
1178697
CUSIP
83548F408
ISIN
US83548F4081
LEI
549300LVHTR09ZVBSB66
EIN
94-3336783

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Michael C. MulicaActing CEO, Director54,071
Hao Peter LiuChief Executive Officer, Director269,388
Clayton CroliusChief Financial Officer36,719
Charles BecherSee Remarks62,668
George ThangaduraiDirector723
Jack SteenstraDirector49,139
Jeffrey WangDirector1,967,647
James S. CassanoDirector49,126

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2024
Hao (Peter) Liu
$672.92K-$134.33K$624.08K$34–
FY2024
Hao Peter Liu
$672.92K-$134.33K$624.08K$34–
FY2023
Hao (Peter) Liu
$677.27K$2.14M$626.14K$80–
FY2023
Hao Peter Liu
$677.27K$2.14M$626.14K$80–
FY2022
Hao (Peter) Liu
$1.99M$1.98M$420.55K$46–
FY2022
Hao Peter Liu
$1.99M$1.98M$420.55K$46–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“We had four full-time employees and four contractors as of December 31, 2025 as part of continuing operations.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 14, 2026Late filingNotification of late filing
May 27, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 15, 2026Late filingNotification of late filing
Apr 30, 2026Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 1, 2026Late filingNotification of late filing
Mar 2, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 27, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 23, 2026Name changeName changed from SONIM TECHNOLOGIES INC to DNA X, Inc.
Dec 18, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 5, 2025Merger voteDefinitive merger proxy statement
Oct 20, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 27, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 14, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 5, 2025Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 21, 2025ListingRegistration of securities on an exchange (Form 8-A)
Mar 14, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Sep 18, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Feb 21, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 22, 2022Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Feb 18, 2022Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Apr 28, 2021Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jan 21, 2021Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jul 28, 2020Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 13, 2019IPOInitial public offering priced (424B4 prospectus)
May 9, 2019ListingRegistration of securities on an exchange (Form 8-A)